Clinical trials for T-cell prolymphocytic leukemia
6 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT06810778Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Jonsson Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGPhase 1NCT04629729FT819 in Subjects With B-cell MalignanciesFate Therapeutics · PI: Fate Trial Disclosure
- ACTIVE NOT RECRUITINGPhase 1NCT04684563huCART19-IL18 in CD19+ CancersUniversity of Pennsylvania · PI: Jakub Svoboda, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04732845Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid MalignanciesBenjamin Tomlinson · PI: Benjamin Tomlinson, MD
- RECRUITINGNCT04411043Observatory of Prolymphocytic Leukemia TFrench Innovative Leukemia Organisation · PI: Kamel LARIBI, Dr
- ACTIVE NOT RECRUITINGPhase 1NCT00586391CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLLBaylor College of Medicine · PI: Carlos Ramos, MD